Literature DB >> 2521323

Ovarian stimulation with pure follicle-stimulating hormone/human menopausal gonadotropin and improved laparoscopic aspiration needles influence the success of an in vitro fertilization program.

J Eisermann1, V Yang, K Register, N Swank, R C Strickler.   

Abstract

The effect of a combined pure follicle-stimulating hormone/human menopausal gonadotropin (pFSH/hMG) ovarian stimulation regimen and modified, sharpened laparoscopic follicular aspiration needles on the number of oocytes retrieved and the oocyte/follicle ratio in 43 consecutive cycles of in vitro fertilization (IVF) were retrospectively compared with 99 consecutive preceeding cycles stimulated with hMG alone and captured with aspiration needles that had never been sharpened. A modified laparoscopic follicular aspiration needle is described. Purified FSH/hMG ovarian stimulation significantly improved the mean serum estradiol levels, number of preovulatory follicles, and, therefore, the total number of oocytes recovered per cycle. The mean ratios of oocytes recovered per preovulatory follicle documented on ultrasound, and per aspirated follicle, increased significantly using sharpened needles. Both modifications improved the success rate of our IVF program.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2521323     DOI: 10.1016/s0015-0282(16)60438-7

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  2 in total

Review 1.  The use of follicle flushing during oocyte retrieval in assisted reproductive technologies: a systematic review and meta-analysis.

Authors:  Gary Levy; Micah J Hill; Christina I Ramirez; Luiz Correa; Mary E Ryan; Alan H DeCherney; Eric D Levens; Brian W Whitcomb
Journal:  Hum Reprod       Date:  2012-05-30       Impact factor: 6.918

2.  The effects of IVF aspiration on the temperature, dissolved oxygen levels, and pH of follicular fluid.

Authors:  Gabe P Redding; John E Bronlund; Alan L Hart
Journal:  J Assist Reprod Genet       Date:  2006-03-15       Impact factor: 3.412

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.